Keith Howard work email
- Valid
- Valid
- Valid
Keith Howard personal email
Senior management experience in the non-clinical and safety testing on inactivated whole virus vaccines (seasonal and avian influenza, SARS CoV, alphaviruses, flaviviruses). Experience in leading the analytical development and process development activities supporting the manufacture of inactivated and live recombinant viral vaccines and gene therapy vectors. Interested in the development of vaccines and biopharmaceutical therapeutics for any unmet need. Molecular biologist with practical and project management experience in parasitology (trypanosome: life cycle progression and diagnostics), virology (herpes virus latency), gene therapy (HSV and AAV vectors), and recombinant vaccines (plasmid, HSV, MVA, fowlpox, adenovirus vectors). Specialties: Molecular Parasitology, Molocular Virology, Research, Process Development, Analytical Development, Regulatory Submissions (Phase I, II, III: Europe and US).
Avaxipen Ltd
-
Chief Scientific OfficerAvaxipen Ltd Oct 2020 - PresentaVaxziPen is an innovative pharmaceutical company developing needle-free, solid dose, injectable products with potential to transform performance and delivery of vaccines and make a material impact on global healthcare.The company’s primary focus is the development of novel solid dose vaccines against a range of infectious and other select diseases, working in partnership with global companies, government agencies and non-governmental organisations.
-
Chief Development OfficerVaccitech Limited Feb 2018 - Jul 2020Oxford, United KingdomHead of Manufacturing. Responsible for leading Research and Development; providing oversight of design, construction, manufacture, and evaluation of vaccine candidates. Responsible for the management of the manufacture of clinical trial material and for the operation and compliance of the Vaccitech's lab facilities.
-
Senior Director, Flu-MsatMedimmune Jun 2017 - Dec 2017Liverpool, United KingdomHead of Department, Manufacturing Science & Technology; supporting the manufacture and process development activities of the Medimmune live attenuated seasonal influenza vaccine, FluMist/Fluenz. MSAT develops and evaluates candidate vaccine seed viruses, develops process improvements, and establishes and improves a range of molecular biology-, virology-, and immunology-based analytical assays. -
Director, Vaccines Analytical DevelomentPfizer Biotech Dec 2014 - May 2017Orth An Der Donau, AustriaHead of department. Management of assay development to support the manufacture and release of licensed vaccines against tick-borne encephalitis and Meningitis C. Additional small scale upstream model activities to support TBEV vaccine manufacturing and process development. -
Director R&DBaxter Innovations Gmbh Jul 2005 - Nov 2014Orth An Der Donau, AustriaHead of Virology R&D. Management of non-clinical research on prophylactic inactivated whole virus vaccines to seasonal influenza, pandemic and avian influenza, Tick-borne encephalitis virus, SARS corona virus, Ross River virus, chikungunya virus and other emerging viruses. Additionally providing support to clinical, quality, manufacturing, regulatory and marketing functions from non-clinical research through to licensure and life cycle management activities. -
Head Of Vector DevelopmentOxxon Therapeutics Jan 2002 - Jun 2005Oxford, United KingdomManagement of R&D Group constructing therapeutic vaccines to cancer and chronic infections (melanoma, hepatitis B, HIV) based on recombinant plasmids, MVA, fowlpox, HSV, and adenovirus vectors. Established and managed Virology Group, Process Development Group and analytical support. -
Director Of Neuronal Gene TherapyCantab Pharmaceuticals Ltd Apr 1997 - Dec 2001Responsible for the design and construction of a highly disabled HSV1 vector system based on the DISC-HSV vaccine. Project manager for the design and construction of gene therapy vectors for lysosomal storage diseases (Gaucher's) and Parkinson's Disease. Managed the process development team during the establishment of a scaleable purification process for HSV1 vectors.
-
Senior Research FellowUniversity College London 1990 - 1997
-
Research TechnicianWolfson Molecular Biology Unit, Lshtm 1984 - 1990
Keith Howard Skills
Keith Howard Education Details
-
Biological Sciences -
Helsby Grammar
Frequently Asked Questions about Keith Howard
What company does Keith Howard work for?
Keith Howard works for Avaxipen Ltd
What is Keith Howard's role at the current company?
Keith Howard's current role is Chief Scientific Officer at aVaxziPen Ltd.
What is Keith Howard's email address?
Keith Howard's email address is ke****@****ter.com
What schools did Keith Howard attend?
Keith Howard attended University Of Leicester, Helsby Grammar.
What skills is Keith Howard known for?
Keith Howard has skills like Virology, Vaccines, R&d, Project Management, Biopharmaceuticals, Immunology, Biotechnology, Analytical Chemistry, Molecular Virology, Gene Therapy, Viral Vectors, Assay Development.
Not the Keith Howard you were looking for?
-
Keith Howard
Professor Emeritus, And Leverhulme Emeritus Fellow At Soas University Of LondonGreater Oxford Area1soas.ac.uk -
Keith Howard
Helping Teams Discover Their Purpose.Chief Engineer. Ceng. Fimeche. Propulsion Software, Calibration And Controls. Prognostics And Data Analytics.Greater Coventry Area3jaguarlandrover.com, callnetuk.com, ford.com2 (313) 3XXXXXXX
-
1porterbrook.co.uk -
2bayonetventures.com, bayonet.ventures.com
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial